There’s a growing use of AI in life sciences for everything from planning to marketing. About 95% of respondents in a recent life science industry survey believe that generative AI shapes their company’s direction more than rising costs or shifting consumer preferences.
However, despite AI already doing so much in this industry, the major tasks it handles these days are mostly centred around data collection and analysis. That’s why high-quality AI data services are now critical for research, clinical development, and healthcare operations. We’ll go over AI data services, their key applications and more.
What Are AI Data Services?
AI data services are the specialised processes and expertise that are used to prepare and refine the large amount of data used in training AI and machine learning (ML) models. These services are what ensure that the models deliver accurate and quality output when you use them. In life science, where data is often fragmented, sensitive, and requires deep domain knowledge to interpret, data services are very important.
Data annotation, data labelling, NLP datasets, medical image datasets, data collection and data validation are just a few of these necessary services. Each of these transforms raw data, such as patient records or scientific literature into structured formats that AI can learn from. Here’s a breakdown of the role each service plays:
- Data collection and curation: Ethical sourcing and organising different raw data, while also cleaning the collected data and standardising it for consistency.
- Data annotation and labelling: This step is where adding diverse tags, bounding and data classification occur. A good example of what this step looks like is experts labelling medical image datasets like CT scans to identify disease markers or tag text in clinical notes to create NLP datasets.
- Data validation: At this stage, the data needs to be checked rigorously for accuracy, completeness and possible bias. That way the training data is nothing but verifiable truth with little to no errors in the eventual AI model.
Key Applications of AI Data Service in the Life Sciences Industry
Without AI data services, there’d be no AI systems that help to deliver breakthroughs efficiently and quickly. These are four key applications of AI data services in the life science industry and how impactful they are:
Drug discovery and early research
The application of AI in the early stages of research eases the otherwise slow and costly process of identifying viable drug candidates. AI data services are there to provide the structured data that moves drug design from basic trial and error to more targeted and predictive. Here’s how:
Literature mining: Clues about new disease mechanics and potential drug targets are scattered across patents, scientific publications and clinical reports, all of which are unstructured texts. With NLP datasets created by annotating these unstructured texts to spot biomedical entities like diseases, proteins, and genes, AI models are able to perform literature mining.
Molecule prediction and simulation: AI models are trained on structured biological and chemical datasets such as the properties of millions of existing compounds. That’s a training process that relies heavily on specialised data annotation of toxicity data, molecular structures and reaction outcome. This enables AI to perform predictive modelling, determining the efficacy and potential side effects of novel molecules in silico.
Target identification: When AI algorithms are trained on annotated genomic, proteomic, and transcriptomic data, they can analyse how complex biological systems respond to changes. This method allows for the early validation and prioritisation of likely therapeutic targets, increasing the chance of success in later clinical trials.
Clinical Trials
Clinical trials are usually very expensive and tricky to get willing participants. AI data services are making it a cheaper and more precise process by cutting time and easily identifying ideal participants in the following ways:
Patient matching and recruitment: Participant recruitment is one of the biggest causes of delays in clinical trials. With the right NLP data, an AI model can match the complex inclusion/exclusion criteria of a trial against a large patient population. Such accurate patient matching makes trials faster and includes the most relevant candidates, which is great for the statistical power of eventual results.
Automated data cleaning and annotation: Data is useful for flagging data anomalies and filling missing values during a trial so that there’s consistency. This, in conjunction with underlying data validation and curation services, helps automate data cleaning.
Image annotation and endpoint assessment: In clinical trials in oncology and ophthalmology, artificial intelligence models, which are trained on medical picture datasets with expert annotations, can give objective and consistent evaluations of how diseases progress. Image annotation is vital for fair evaluation of endpoints. It speeds up decision-making and reduces differences in how people interpret visual data.
Real-world data analysis: Post-trial analyses and regulatory submissions are increasingly using real-world data (RWD), which is often unstructured and complex. AI data services take real-world data from sources like claims databases and patient registries, and then they structure that information. This structured data allows AI to assess how well treatments work in the real world.
Diagnostics and Healthcare
Artificial intelligence is a major part of the trend towards personalised and accurate medicine. However, its accuracy depends entirely on the quality of the data used to train it, especially in complicated fields like medical imaging and clinical documentation.
Medical imaging datasets: Creating artificial intelligence that can recognise small details in medical scans requires large datasets of medical images that have been perfectly labelled. Expert annotators carefully label tissues, diseases, and anatomical features. This includes tasks like precisely identifying tumour margins on a pathology slide.
NLP for clinical notes: A lot of important patient information, including details about symptoms, family history, and how well treatments worked, is currently hidden in the unstructured text of doctors’ notes. Named Entity Recognition and Relation Extraction in AI are made possible by annotating text, which creates the datasets used in Natural Language Processing. This process quickly converts messy clinical notes into organised, searchable information. It then gives clinicians crucial, patient-specific insights, which are used in clinical decision support systems.
Diagnostic model training: Besides imaging, artificial intelligence models are developed using combined data from many sources. Some of these are genomic sequences, clinical lab results, and lifestyle information for forecasting disease risk or how well a medicine would work. AI data services are the glue that holds everything together, providing the essential data connections and uniform labelling needed for these varied data sources.
Regulatory and Post-market Work
Ensuring compliance and protecting patient safety needs ongoing attention to the growing amount of data available worldwide. Nowadays, AI simplifies these essential, data-heavy operations:
Pharmacovigilance data and safety monitoring: The usual way of finding adverse events is slow and mostly doesn’t capture all the reports. With the right pharmacovigilance training, AI models can accurately analyse information from global sources. They can also use natural language processing to monitor safety in real time. That way, it is easy to identify possible issues, categorise events, and prioritise cases for human assessment.
Compliance documentation: Compliance documentation and real-time auditing are now possible with AI systems that are trained with precise regulatory data annotation. They can keep pace with changing compliance standards, including regulations from the FDA, EMA, and other global and local authorities.
Conclusion
The right AI data services are both cost- and time-saving. They handle everything from providing precise labelling and validation data to improving the speed of drug discovery. Overall, they are now a necessity as life sciences advance, especially when it comes to providing the right products, getting approvals, and launching drugs in new markets in a timely fashion
At EC Innovations, our experts provide AI data services to support drug development, clinical research, and healthcare innovation. Contact us now for a quick consultation or to discuss customised AI data solutions.
